Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.9% beneficial ownership stake in Barrick Gold Corp common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in BioMarin Pharmaceutical, Reports 10.8% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 10.8% of BioMarin Pharmaceutical Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.0% passive beneficial ownership stake in Teck Resources Ltd. as of March 31, 2025.
NYSE
Investment giant BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.2% beneficial ownership stake in MediaAlpha, Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.4% Passive Stake in Koninklijke Philips NV
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.4% in Koninklijke Philips NV as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 12.2% in Fabrinet's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% beneficial ownership stake in B2Gold Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 3.5% in HBT Financial, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 4.1% passive beneficial ownership stake in Ferrari N.V. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.3% beneficial ownership stake in Cameco Corp as of March 31, 2025, indicating a passive investment position.
NYSE
SCHEDULE 13G/A: BlackRock Reduces Stake in Black Diamond Therapeutics to 4.5%
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.5% beneficial ownership stake in Black Diamond Therapeutics, Inc. as of March 31, 2025, indicating a reduction from a previously reportable position.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.9% Stake in Vale S.A. in Latest SEC Filing
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 4.9% of Vale S.A.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.6% beneficial ownership stake in DraftKings Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.9% beneficial ownership stake in ATN International, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, confirming its passive beneficial ownership of 3.7% of Unity Software Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Bit Digital, Inc., Reporting 4.2% Beneficial Ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.2% beneficial ownership stake in Bit Digital, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.9% of Crawford & Co.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% beneficial ownership stake in Surgery Partners, Inc. as of March 31, 2025, indicating a passive investment.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.5% passive beneficial ownership stake in Accel Entertainment, Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains 5.0% Stake in KB Financial Group Inc.
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a continued beneficial ownership of 5.0% in KB Financial Group Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.3% Passive Stake in Stantec Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.3% of Stantec Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 3.7% passive beneficial ownership stake in Orchestra BioMed Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 4.7% of Carnival PLC's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Dr. Reddy's Laboratories, Reports 4.1% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.1% beneficial ownership stake in Dr. Reddy's Laboratories Ltd. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 3.8% beneficial ownership stake in Wix.com Ltd. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.9% Passive Stake in Suncor Energy Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership stake in Suncor Energy Inc. as of March 31, 2025, held for ordinary course of business.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.5% beneficial ownership stake in Nuvalent, Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 4.3% beneficial ownership stake in Donegal Group Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.9% beneficial ownership stake in Live Nation Entertainment, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.8% Stake in Compass Minerals International
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.8% beneficial ownership stake in Compass Minerals International Inc. as of March 31, 2025.